(Q51771485)

English

Predictors of early response to infliximab in patients with ulcerative colitis.

scientific article published in February 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17206703

Predictors of early response to infliximab in patients with ulcerative colitis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17206703

Séverine Vermeire

2

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17206703

Gert Van Assche

5

object named as

Gert Van Assche

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

11

object named as

Paul Rutgeerts

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

1

object named as

Marc Ferrante

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17206703

4

object named as

Maja Noman

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17206703

7

object named as

Ingrid Arijs

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17206703

9

object named as

Ilse Hoffman

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17206703

Fabian Schnitzler

6

object named as

Fabian Schnitzler

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17206703

author name string

Konstantinos H Katsanos

3

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17206703

Gert De Hertogh

8

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17206703

J Karel Geboes

10

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17206703

publication date

1 February 2007

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17206703

Inflammatory Bowel Diseases

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17206703

13

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17206703

2

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17206703

123-128

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17206703

Medical therapy for ulcerative colitis 2004.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20054

21 January 2018

Intensive intravenous regimen for severe attacks of ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20054

21 January 2018

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20054

21 January 2018

Infliximab for the treatment of fistulas in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20054

21 January 2018

Ciclosporin use in acute ulcerative colitis: a long-term experience

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20054

21 January 2018

Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20054

21 January 2018

Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20054

21 January 2018

Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20054

21 January 2018

Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20054

21 January 2018

Infliximab for induction and maintenance therapy for ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20054

21 January 2018

Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20054

21 January 2018

A reproducible grading scale for histological assessment of inflammation in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20054

21 January 2018

Are there predictors of Remicade treatment success or failure?

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20054

21 January 2018

ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20054

21 January 2018

Predictors of response to infliximab in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20054

21 January 2018

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20054

21 January 2018

Identifiers

10.1002/IBD.20054

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17206703

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17206703

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51771485&oldid=1743568400"